Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 1999

View Archived Issues

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

Fujisawa updates R&D activities for FY 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

Ribonucleoside reductase inhibitors with anti-HIV activity in development at Molecules for Health

Proteus and Therapeutic Antibodies propose merger

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

New MMP/TNF production inhibitors presented by DuPont

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

Immunosuppressive and antifungal sphingosine derivatives from Takara Shuzo

Yoshitomi discloses new antipsychotics in recent patent literature

News from DDW: rhIL-11 has potential in the treatment of pancreatitis

Improved PDE4 inhibitors in development at Merck Frosst

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

Japanese herbal medicine improves symptoms of nonulcer dyspepsia

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

ViroPharma to advance new anti-RSV candidate to clinical trials

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

Avigen cleared to begin human trials of gene therapy product for hemophilia

New series with potential in HCV disease advances through the ViroPharma pipeline

NeoPharm outlines developments during the first quarter

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

SmithKline Beecham launches antidiarrheal drug in the Philippines

Fluvoxamine maleate launched in Japan for social anxiety disorder

Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial

CPMP adopts positive opinion on Synagis for RSV prevention

Flavonoid derivative DA-6034 is active in animal models of IBD

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

Avandia receives FDA approval for treatment of type II diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...